Table 1. Correlation between the expression level of miR-155 with clinicopathological features.
Clinicopathological features | Low miR-155 | High miR-155 | Total | P-value |
---|---|---|---|---|
Gender | ||||
Male | 9 | 9 | 18 | 0.692 |
Female | 2 | 3 | 5 | |
Age | ||||
≥ 63 | 6 | 6 | 12 | 0.827 |
< 62 | 5 | 6 | 11 | |
Location | ||||
Sacrum | 10 | 10 | 20 | 0.59 |
Other | 1 | 2 | 3 | |
Stage | ||||
1A + 1B | 9 | 4 | 13 | 0.036a |
2A + 2B + 3 | 2 | 8 | 10 | |
Origin | ||||
Primary origin | 8 | 4 | 12 | 0.059 |
Recurrent origin | 3 | 8 | 11 | |
Local recurrence | ||||
Overall | ||||
Yes | 5 | 6 | 11 | 0.827 |
No | 6 | 6 | 12 | |
Primary origin | ||||
Yes | 3 | 0 | 3 | 0.157 |
No | 5 | 4 | 9 | |
Recurrent origin | ||||
Yes | 2 | 6 | 8 | 0.782 |
No | 1 | 2 | 3 | |
Metastasis | ||||
Yes | 0 | 4 | 4 | 0.035a |
No | 11 | 8 | 19 |
The relationships of the high and low expression group of miR-155 with clinicopathological features of chordoma patients were analyzed by chi-squared test.
Indicates statistical significance. Statistical significance was defined as a P-value of < 0.05.